Pharma stocks has outperformed the MSCI India Index by 40% in the last three years. However, several looming challenges threaten the momentum in many of the stocks. Scroll down for three names that the analysts continue to be bullish on.
Pharma stocks has outperformed the MSCI India Index by 40% in the last three years. However, several looming challenges threaten the momentum in many of the stocks. Scroll down for three names that the analysts continue to be bullish on.